Regulation of hepatitis C virus translation initiation by iron: Role of eIF3 and La protein

Virus Research

Volumn 167, Issue 2, 2012, Pages 302-309

  Wang, Qiang ^a,b   Liu, Yiping ^c   An, Daizhi ^b   Diao, Hongyan ^a   Xu, Wei ^a   He, Xiang ^b   Sun, Rubao ^b   Wei, Li ^a   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c Beijing Municipal Public Security Bureau   (China)

Author keywords

Eukaryotic initiation factor; Hepatitis C virus; Internal ribosome entry site; Iron

Indexed keywords

INITIATION FACTOR; INITIATION FACTOR 3; IRON; LA ANTIGEN; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; GENE CONSTRUCT; GENE SEQUENCE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; IRON CHELATION; IRON OVERLOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS TRANSCRIPTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; EUKARYOTIC INITIATION FACTOR-3; GENE EXPRESSION PROFILING; GENES, REPORTER; HEPACIVIRUS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; IRON; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; REAL-TIME POLYMERASE CHAIN REACTION;

EUKARYOTA; HEPATITIS C VIRUS;

EID: 84863867085     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.05.014     Document Type: Article

References (30)

1. Akiyoshi F., Sata M., Uchimura Y., Suzuki H., Tanikawa K. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: a predictive marker for IFN therapy. American Journal of Gastroenterology 1997, 92(9):1463-1466.
2. Ali N., Siddiqui A. The La antigen binds 5' noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation. Proceedings of the National Academy of Sciences of the United States of America 1997, 94(6):2249-2254.
3. Ali N., Siddiqui A. Interaction of polypyrimidine tract-binding protein with the 5' noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of translation. Journal of Virology 1995, 69(10):6367-6375.
4. Angelucci E., Muretto P., Nicolucci A., Baronciani D., Erer B., Gaziev J., Ripalti M., Sodani P., Tomassoni S., Visani G., Lucarelli G. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation. Blood 2002, 100(1):17-21.
5. Cai Q., Todorovic A., Andaya A., Gao J., Leary J.A., Cate J.H. Distinct regions of human eIF3 are sufficient for binding to the HCV IRES and the 40S ribosomal subunit. Journal of Molecular Biology 2010, 403(2):185-196.
6. Cho H., Lee H.C., Jang S.K., Kim Y.K. Iron increases translation initiation directed by internal ribosome entry site of hepatitis C virus. Virus Genes 2008, 37(2):154-160.
7. Chung R.T., Kaplan L.M. Heterogeneous nuclear ribonucleoprotein I (hnRNP-I/PTB) selectively binds the conserved 3' terminus of hepatitis C viral RNA. Biochemical and Biophysical Research Communications 1999, 254(2):351-362.
8. Conjeevaram H.S., Everhart J.E., Hoofnagle J.H. Predictors of a sustained beneficial response to interferon-alpha therapy in chronic hepatitis C. Hepatology 1995, 22(4 Pt 1):1326-1329.
9. Dasgupta A., Das S., Izumi R., Venkatesan A., Barat B. Targeting internal ribosome entry site (IRES)-mediated translation to block hepatitis C and other RNA viruses. FEMS Microbiology Letters 2004, 234(2):189-199.
10. Desai T.K., Jamil L.H., Balasubramaniam M., Koff R., Bonkovsky H.L. Phlebotomy improves therapeutic response to interferon in patients with chronic hepatitis C: a metaanalysis of six prospective randomized controlled trials. Digestive Diseases and Sciences 2008, 53(3):815-822.
11. Di Marco V., Capra M., Angelucci E., Borgna-Pignatti C., Telfer P., Harmatz P., Kattamis A., Prossamariti L., Filosa A., Rund D., Gamberini M.R., Cianciulli P., De Montalembert M., Gagliardotto F., Foster G., Grangè J.D., Cassarà F., Iacono A., Cappellini M.D., Brittenham G.M., Prati D., Pietrangelo A., Craxì A., Maggio A. Italian Society for the Study of Thalassemia and Haemoglobinopathies, Italian Association for the Study of the Liver. Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel. Blood 2010, 116(16):2875-2883.
12. Domitrovich A.M., Diebel K.W., Ali N., Sarker S., Siddiqui A. Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication. Vaccine 2005, 335(1):72-86.
13. Dong Z., Zhang J.T. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Molecular Biology of the Cell 2003, 14(9):3942-3951.
14. Fujita N., Sugimoto R., Urawa N., Araki J., Mifuji R., Yamamoto M., Horiike S., Tanaka H., Iwasa M., Kobayashi Y., Adachi Y., Kaito M. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. Journal of Gastroenterology and Hepatology 2007, 22(11):1886-1893.
15. Furutani T., Hino K., Okuda M., Gondo T., Nishina S., Kitase A., Korenaga M., Xiao S.Y., Weinman S.A., Lemon S.M., Sakaida I., Okita K. Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 2006, 130(7):2087-2098.
16. Hayashi H., Takikawa T., Nishimura N., Yano M., Isomura T., Sakamoto N. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. American Journal of Gastroenterology 1994, 89(7):986-988.
17. Herrera J.L. Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy. American Journal of Gastroenterology 1999, 94(12):3571-3575.
18. Honda M., Shimazaki T., Kaneko S. La protein is a potent regulator of replication of hepatitis C virus in patients with chronic hepatitis C through internal ribosomal entry site-directed translation. Gastroenterology 2005, 128(2):449-462.
19. Hwang S.J., Chen L.K. Chronic hepatitis C and diabetes mellitus. Journal of the Chinese Medical Association 2006, 69(4):143-145.
20. Kadiiska M.B., Burkitt M.J., Xiang Q.H., Mason R.P. Iron supplementation generates hydroxyl radical in vivo: an ESR spin-trapping investigation. Journal of Clinical Investigation 1995, 96(3):1653-1657.
21. Kieft J.S., Zhou K., Jubin R., Doudna J.A. Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA 2001, 7(2):194-206.
22. Maraia R.J., Intine R.V. Recognition of nascent RNA by the human La antigen: conserved and divergent features of structure and function. Molecular and Cellular Biology 2001, 21(2):367-379.
23. Olynyk J.K., Reddy K.R., Di Bisceglie A.M., Jeffers L.J., Parker T.I., Radick J.L., Schiff E.R., Bacon B.R. Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 1995, 108(4):1104-1109.
24. Pawlotsky J.M., Roudot-Thoraval F., Bastie A., Darthuy F., Rémiré J., Métreau J.M., Zafrani E.S., Duval J., Dhumeaux D. Factors affecting treatment responses to interferon-alpha in chronic hepatitis C. Journal of Infectious Diseases 1996, 174(1):1-7.
25. Pestova T.V., Shatsky I.N., Fletcher S.P., Jackson R.J., Hellen C.U. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes and Development 1998, 12(1):67-83.
26. Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. Journal of Hepatology 1998, 28(Suppl. 1):8-13.
27. Shimazaki T., Honda M., Kaneko S., Kobayashi K. Inhibition of internal ribosomal entry site-directed translation of HCV by recombinant IFN-alpha correlates with a reduced La protein. Hepatology 2002, 35(1):199-208.
28. Spångberg K., Schwartz S. Poly(C)-binding protein interacts with the hepatitis C virus 5' untranslated region. Journal of General Virology 1999, 80(Pt6):1371-1376.
29. Theurl I., Zoller H., Obrist P., Datz C., Bachmann F., Elliott R.M., Weiss G. Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3. Journal of Infectious Diseases 2004, 190(4):819-825.
30. Van Thiel D.H., Friedlander L., Fagiuoli S., Wright H.I., Irish W., Gavaler J.S. Response to interferon alpha therapy is influenced by the iron content of the liver. Journal of Hepatology 1994, 20(3):410-415.